| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 800,993 | 954,566 | 841,566 | 839,267 | | Cost of Revenue | 669,142 | 748,300 | 710,263 | 744,445 | | | Gross Profit | 131,851 | 206,266 | 131,303 | 94,822 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 90,658 | 88,473 | 82,815 | 103,588 | | Non Recurring | 18,233 | (12,062) | 5,089 | 389,222 | | Others | 15,958 | 15,421 | 15,605 | 17,747 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,002 | 114,434 | 27,794 | (415,735) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,524 | 1,086 | 1,384 | 6,341 | | Earnings Before Interest And Taxes | 24,810 | 109,757 | 34,941 | (399,073) | | Interest Expense | 15,329 | 15,734 | 16,272 | 15,427 | | Income Before Tax | 9,481 | 94,023 | 18,669 | (414,500) | | Income Tax Expense | 4,400 | 5,100 | (4,500) | (3,400) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,081 | 88,923 | 23,169 | (411,100) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (818) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,081 | 88,923 | 23,169 | (411,918) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,081 | $88,923 | $23,169 | ($411,918) |
|
0.36% Nasdaq 
Income Statement
